Journal profile · Medicine-Radiology, Nuclear Medicine and Imaging
Frontiers in Nuclear Medicine
ISSN 2673-8880 · Frontiers Media S.A. · Switzerland
Frontiers in Nuclear Medicine: CAS Zone 4 · Medicine (2026 Xinrui edition); impact factor 2.5 (journal website); fully open access; APC charged, amount not published; median 57 days to acceptance (72 articles, last 24 months); 36 articles in 2025; indexed in ESCI and Scopus.
Scope
Aims, scope and focus
Frontiers in Nuclear Medicine is published by Frontiers Media S.A. and is classed under Medicine in the CAS Journal Ranking. By OpenAlex counts of its recent articles, its largest topics are Medical Imaging Techniques and Applications, Radiopharmaceutical Chemistry and Applications and Radiomics and Machine Learning in Medical Imaging, together about 44.5% of its articles. Its main subfields are Radiology, Nuclear Medicine and Imaging. (generated from OpenAlex topic counts and CAS ranking data)
Frontiers in Nuclear Medicine is a multidisciplinary journal that advances the use of nuclear medicine in diagnostics and therapeutics as an essential part of patient care. Led by Field Chief Editor Prof Adriaan A. Lammertsma (University Medical Center Groningen, Netherlands) and an outstanding international editorial board, Frontiers in Nuclear Medicine publishes research that is dedicated to the application and development of nuclear medicine techniques for diagnostic and/or therapeutic purposes across all major subspecialties involved, including: dosimetry and radiation safety PET and SPECT physics and data analysis radiomics and artificial intelligence radionuclide therapy radiopharmacy and radiochemistry. Frontiers in Nuclear Medicine welcomes research studies that include advances in technology, diagnostics studies, AI applied to image interpretation, as well as studies on radionuclide therapy. In addition, the journal welcomes studies on the synthesis and evaluation of novel radiotracers, studies that aim to quantify radiotracer uptake, as well as novel multi-disciplinary and cross-disciplinary studies in nuclear medicine. Finally, research and clinical practice of nuclear medicine in disciplines such as neurology, oncology, cardiology, and inflammatory diseases are encouraged, together with studies in which nuclear medicine methodology is used for drug development and precision medicine. The journal also welcomes submissions which support and advance the UN’s Sustainable Development Goals (SDGs), notably SDG 3: good health and well-being. Manuscripts that focus solely on the diagnosis or therapy of diseases without applying nuclear medicine techniques are not suitable for publication in this journal. In addition, studies that do not utilize or discuss the application of nuclear medicine methods in their research are not within the scope of this journal. Frontiers in Nuclear Medicine is committed to advancing developments in the field of nuclear medicine by allowing unrestricted access to articles and communicating scientific knowledge to researchers and the public alike, to enable the scientific breakthroughs of the future. Frontiers in Nuclear Medicine is a member of the Committee on Publication Ethics.
From the journal's Aims & Scope
Research area (LetPub): Medicine-Radiology, Nuclear Medicine and Imaging
Editorial board by country: none in mainland China; most named Italy 5, Netherlands 3, United States 2, Türkiye 2, United Kingdom 1 (16 members with a country) Editorial board ↗Publisher website ·
Main research topics OpenAlex counts of recent articles; shares are approximate
- Medical Imaging Techniques and ApplicationsMedicine22.6%
- Radiopharmaceutical Chemistry and ApplicationsMedicine15.2%
- Radiomics and Machine Learning in Medical ImagingMedicine6.6%
- Peptidase Inhibition and AnalysisMedicine4.4%
- Medical Imaging and Pathology StudiesMedicine4.4%
- Cardiac Imaging and DiagnosticsMedicine4.2%
- Advanced MRI Techniques and ApplicationsMedicine4.2%
- Prostate Cancer Treatment and ResearchMedicine3.7%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Not covered
Not covered by this edition.
CAS Xinrui Journal Ranking (March 2026)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Radiology, Nuclear Medicine & Medical Imaging | Zone 4 |
Top journal: noReview journal: not marked
CAS Journal Ranking, previous upgraded edition (December 2023)Not covered
Not covered by this edition.
Database indexing
ESCIScopusDOAJLetPub
International journal early-warning lists: not listed in any editionLetPub
Indexing the journal's website claims
Web of SciencePMCPublisher website
Other: EBSCO, ProQuest, Dimensions, CNKI, CLOCKSS, Crossref
As the journal's website lists them, not checked against each database; for Web of Science editions the records above apply.
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- Impact factor (publisher)
- 2.5Publisher website ·
- CiteScore 2026-06
- 3.1LetPub ·
- CiteScore (publisher)
- 3.1Publisher website ·
- SJR 2026-06
- 0.62LetPub ·
- SNIP 2026-06
- 0.64LetPub ·
- h-index
- 18OpenAlex ·
- i10-index
- 45OpenAlex ·
- 2-year mean citedness
- 3.74OpenAlex ·
- Self-citation rate
- 4%LetPub ·
- Share of gold OA articles
- 100%LetPub ·
Volume
- Articles per year
- 30LetPub ·
Articles by year OpenAlex count · 244 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 31 | 31 | 9 |
| 2025 | 36 | 36 | 89 |
| 2024 | 37 | 37 | 291 |
| 2023 | 57 | 57 | 328 |
| 2022 | 45 | 45 | 379 |
| 2021 | 7 | 7 | 62 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
Review time from article dates manuscript dates registered with PubMed · to
57 daysMedian, submission to acceptance · P25–P75 39 days – 90 days
- Acceptance to online
- median 20 days (72 articles)
- Submission to online
- median 81 days
- Sample
- 72 articles with submission and acceptance dates (78 in the window); the latest was accepted on
Only articles that were accepted and published are counted, not the time spent on rejected manuscripts, so this usually runs longer than a publisher's "time to first decision".
Other sources
- Average review time (community reports)
- about 11 weeksLetPub ·
- Submission to publication (journal-reported)
- about 11 weeksDOAJ ·
- Peer review
- Single anonymous peer reviewDOAJ
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Fully open accessDOAJ
Every article is open access; authors usually pay an article processing charge (APC).
| Source | APC | Fee waiver | License | Observed |
|---|---|---|---|---|
| DOAJ | CHF 1,950 | Yes | CC BY | |
| OpenAlex | CHF 1,950 | — | — | |
| LetPub | USD 2,125 | Yes | — | |
| Publisher website | Yes, amount not published | — | — |
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Submission
Article types and submission policies (journal website)
What to prepare1 items from the author guidelines
- Keywords
- 5–8
Policy excerpts from the journal's websiteAI use, Conflicts of interest, License & copyright, Open access, Peer review
- AI use Use of AI to create written or visual content
Authors should not list a generative AI technology as a co-author or author of any submitted manuscript. Generative AI technologies cannot be held accountable for all aspects of a manuscript and consequently do not meet the criteria required for authorship. If the author of a submitted manuscript has used written or visual content produced by or edited using a generative AI technology, this use mu…
Source ↗Publisher website ·- Conflicts of interest Safeguards against financial conflicts of interest
Only leading researchers acting as Associate Editors, who are not part of Frontiers' staff, can make acceptance decisions based on reviews performed by external experts acting as Community Reviewers or Reviewers. None have a financial incentive to accept articles, i.e. they are not paid for their role as Associate Editor or community Reviewer, and any award scheme is not linked to acceptances of m…
Source ↗Publisher website ·- License & copyright Open access and copyright
All Frontiers' articles from July 2012 onwards are published with open access under the Creative Commons CC-BY license (the current version is CC-BY, version 4.0). This means that the author(s) retains copyright, but the content is free to download, distribute, and adapt for commercial or non-commercial purposes, given appropriate attribution to the original article. Upon submission, the author(s)…
Source ↗Publisher website ·- Open access Open access and copyright
Figures, tables, and images are published under a Creative Commons CC-BY license; permission must be obtained for copyrighted material from other sources. Model summary
All Frontiers' articles from July 2012 onwards are published with open access under the Creative Commons CC-BY license (the current version is CC-BY, version 4.0). This means that the author(s) retains copyright, but the content is free to download, distribute, and adapt for commercial or non-commercial purposes, given appropriate attribution to the original article. Upon submission, the author(s)…
Source ↗Publisher website ·- Peer review Peer review
CrossMark is applied to alert readers to changes and provide the current version of content. Model summary
Our rigorous, transparent peer review process combines expert review and constructive dialogue to strengthen your manuscript.
Source ↗Publisher website ·
Excerpts are quoted from the journal's website; "model summary" lines are written by Workers AI and checked against the text. The journal's website is authoritative.
Profile
Publication details and official links
- Publisher
- Frontiers Media S.A.
- Country or region
- Switzerland
- Language
- English
- ISSN
- 2673-8880
- Official links
- Journal homepage ↗LetPub
- Submission system ↗Publisher website
- Author guidelines ↗DOAJ
- Aims & Scope ↗DOAJ
- Special issues ↗Publisher website
- APC information ↗DOAJ
- Fee waivers ↗DOAJ
- Open access statement ↗DOAJ
- License & copyright ↗DOAJ
- Peer review process ↗LetPub
- Editorial board ↗DOAJ
- Plagiarism policy ↗DOAJ
FAQ
Frequently asked questions about Frontiers in Nuclear Medicine
What CAS zone is Frontiers in Nuclear Medicine in?
In the 2026 Xinrui edition it is in Zone 4 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.
What is the impact factor of Frontiers in Nuclear Medicine?
The journal's website gives an impact factor of 2.5; this is the journal's own figure, as LetPub lists none for it; CiteScore 3.1, h-index 18.
How long does peer review take at Frontiers in Nuclear Medicine?
Based on the dates recorded on 72 articles published between October 2024 and October 2026 (the last 24 months), the median time from submission to acceptance is 57 days (interquartile range 39–90 days); authors report an average review time of about 11 weeks. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
Where are the editorial board members of Frontiers in Nuclear Medicine based?
Of the 16 board members whose country the journal's board page names, none are in mainland China; the countries named most often are Italy (5), Netherlands (3) and United States (2). Counted from the institutions listed on the board page; for reference only.
Which databases index Frontiers in Nuclear Medicine?
According to LetPub and DOAJ records, Frontiers in Nuclear Medicine is indexed in ESCI, Scopus and DOAJ. The journal's website also lists Web of Science and PMC; that list has not been checked against each database.
Is Frontiers in Nuclear Medicine open access, and what is the APC?
Frontiers in Nuclear Medicine is a fully open-access journal. APC charged, amount not published.
Sources and updates
The facts on this page come from LetPub, OpenAlex, Publisher website, DOAJ; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-25). Last updated: .